0001209191-21-011775.txt : 20210218
0001209191-21-011775.hdr.sgml : 20210218
20210218160018
ACCESSION NUMBER: 0001209191-21-011775
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210216
FILED AS OF DATE: 20210218
DATE AS OF CHANGE: 20210218
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Lundberg Sven Ante
CENTRAL INDEX KEY: 0001682126
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37773
FILM NUMBER: 21649427
MAIL ADDRESS:
STREET 1: C/O CRISPR THERAPEUTICS AG
STREET 2: 200 SIDNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Merus N.V.
CENTRAL INDEX KEY: 0001651311
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: P7
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: YALELAAN 62
CITY: 3584 CM UTRECHT
STATE: P7
ZIP: 3584 CM
BUSINESS PHONE: 31 030 253 8800
MAIL ADDRESS:
STREET 1: YALELAAN 62
CITY: 3584 CM UTRECHT
STATE: P7
ZIP: 3584 CM
FORMER COMPANY:
FORMER CONFORMED NAME: Merus B.V.
DATE OF NAME CHANGE: 20150819
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-02-16
0
0001651311
Merus N.V.
MRUS
0001682126
Lundberg Sven Ante
C/O MERUS N.V.
YALELAAN 62
UTRECHT
P7
3584 CM
NETHERLANDS
1
1
0
0
President, CEO & PFO
Share Option (right to buy)
24.43
2021-02-16
4
A
0
368000
0.00
A
2031-02-16
Common Shares
368000
368000
D
Options vest over a four-year period from January 1, 2021. 25% vest on January 1, 2022 and in 36 equal monthly installments thereafter.
/s/ Peter Silverman as attorney-in-fact
2021-02-18